Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:THRX

Theseus Pharmaceuticals (THRX) Stock Price, News & Analysis

Theseus Pharmaceuticals logo

About Theseus Pharmaceuticals Stock (NASDAQ:THRX)

Advanced Chart

Key Stats

Today's Range
$4.06
$4.06
50-Day Range
$4.06
$4.07
52-Week Range
$2.05
$12.37
Volume
N/A
Average Volume
592,167 shs
Market Capitalization
$179.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive THRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theseus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

THRX Stock News Headlines

The True Cost of Layoffs
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
Theseus Pharmaceuticals Announces Closing of Tender Offer
Theseus Pharmaceuticals Announces Closing of Tender Offer
See More Headlines

THRX Stock Analysis - Frequently Asked Questions

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) announced its earnings results on Monday, November, 15th. The company reported ($5.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $4.93.

Theseus Pharmaceuticals (THRX) raised $150 million in an initial public offering (IPO) on Thursday, October 7th 2021. The company issued 10,000,200 shares at $14.00-$16.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Theseus Pharmaceuticals investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
11/15/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:THRX
CIK
1745020
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.61 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-24.84%
Return on Assets
-23.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
29.93
Quick Ratio
29.93

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.36 per share
Price / Book
0.76

Miscellaneous

Outstanding Shares
44,230,000
Free Float
23,575,000
Market Cap
$179.57 million
Optionable
Optionable
Beta
3.98
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:THRX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners